HOME HELP FEEDBACK TABLE OF CONTENTS ARCHIVE SUBSCRIPTIONS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Koster, A. Articles by van Krieken, J. H.J.M. Search for Related Content PubMed PubMed Citation Articles by Koster, A. Articles by van Krieken, J. H.J.M.

The prognostic significance of the intra-follicular tumor cell proliferative rate in follicular lymphoma

From the Departments of Hematology (AK, JMMR, MAMK); Pathology (HAT, KH, JHJMvK) and Epidemiology and Biostatistics, Radboud University Nijmegen Medical Center, Nijmegen, the Netherlands (GFB)

Correspondence: John M.M. Raemaekers, Radboud University Nijmegen Medical Center, Department of Hematology 544, PO box 9101, 6500 HB Nijmegen, The Netherlands. E-mail: j.raemaekers{at}hemat.umcn.nl.

Background and Objectives: In follicular lymphoma histological grading is used to predict clinical behavior and to stratify patients for treatment. However, the reproducibility of histological grading is poor and the clinical significance of the difference between grade 1 and grade 2 follicular lymphoma is unclear. Data on proliferation characteristics with respect to prognosis in follicular lymphoma are inconsistent.

Design and Methods: We assessed the Proliferation Index in follicles, using Mib-1 immunohistochemical staining in lymph node biopsies from 51 patients with follicular lymphoma who were receiving uniform first-line treatment consisting of cyclophosphamide, vincristine, prednisone and interferon 2b.

Results: The median Proliferation Index was 16.9 (range 3.1–49.2). In grades 1 and 2 follicular lymphoma (n=45) it was 16.1, compared to 24.2 in grade 3 (n=6; p=0.02). At a median follow-up of 71 months, patients with a Proliferation Index below the median had a significantly prolonged time to progression (median not reached vs. 15 months for those with a Proliferation Index above the median; p =0.0006) and improved overall survival (median not reached vs. 42 months, respectively; p =0.002). In multivariate analysis, the Proliferation Index retained its predictive value. Additional prognostic information was especially provided in patients with a low International Prognostic Index. Histological grade did not predict outcome.

Interpretation and Conclusions: The Proliferation Index is a biological marker that is strongly and independently predictive for outcome in follicular lymphoma, as shown even in this relatively small series of patients. It is easily applicable and reproducible and therefore superior to histological grading in identifying clinically aggressive follicular lymphoma, requiring other types of treatment.

Key words: follicular lymphoma, proliferation, mib-1, prognosis.

This article has been cited by other articles:

				S. Quijano, A. Lopez, A. Rasillo, S. Barrena, M. Luz Sanchez, J. Flores, C. Fernandez, J. M. Sayagues, C. S. Osuna, N. Fernandez, et al. Association between the proliferative rate of neoplastic B cells, their maturation stage, and underlying cytogenetic abnormalities in B-cell chronic lymphoproliferative disorders: analysis of a series of 432 patients Blood, May 15, 2008; 111(10): 5130 - 5141. [Abstract] [Full Text] [PDF]